Bo and I discuss some of the leading candidates for extending both human lifespan and “health-span”, including metformin, nicotinamide riboside & nicotinamide mononucleotide, and caloric restriction. We also chat about some of the companies working in this area, as well as novel business models that may or may not be a strategy to enable rigorous research of something as difficult to study as human lifespan.
All content for Wired to be Weird is the property of Ian McLaughlin & Bo Allen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Bo and I discuss some of the leading candidates for extending both human lifespan and “health-span”, including metformin, nicotinamide riboside & nicotinamide mononucleotide, and caloric restriction. We also chat about some of the companies working in this area, as well as novel business models that may or may not be a strategy to enable rigorous research of something as difficult to study as human lifespan.
Did the concept of addiction always exist, or is it a new concept? Do scientists and physicians all agree that addiction is a disease? We discuss topics like these, as well as a scandal involving the primary study used to make MDMA, or ecstasy, as illegal as a drug can be and a former director of NIDA.
Sponsors:
1. Helix Sleep! Comfortable, customized mattresses. helixsleep.com/wired for $50 off.
2. Burrow! burrow.com. Modular couches (with USB ports, which Bo loves). Use promo code WIRED for $50 off.
3. Harper Wilde! harperwilde.com. Simple, try-at-home bras, made by a company that contributes to the education of young women in over 100 countries. Use promo code WIRED for 10% off
Wired to be Weird
Bo and I discuss some of the leading candidates for extending both human lifespan and “health-span”, including metformin, nicotinamide riboside & nicotinamide mononucleotide, and caloric restriction. We also chat about some of the companies working in this area, as well as novel business models that may or may not be a strategy to enable rigorous research of something as difficult to study as human lifespan.
